Nomenclature for factors of the HL-A system

Area of Science:

• Immunogenetics
• Human Genetics
• Immunology

Background:

• The initial human leukocyte antigen (HLA) nomenclature was established in 1968 by a dedicated committee.
• This nomenclature gained international acceptance and was crucial for advancements in tissue typing and transplantation.
• Subsequent workshops and evolving scientific understanding necessitated a review and update of the original system.

Purpose of the Study:

• To present a revised nomenclature for human leukocyte antigens.
• To incorporate new discoveries and refine the existing system for better clarity and accuracy.
• To provide an updated standard for the international scientific community.

Main Methods:

• A Nomenclature Committee, comprising specialists in tissue typing, immunology, and human genetics, convened.
• The committee reviewed the 1968 memorandum and existing data from histocompatibility testing workshops.
• A revised memorandum detailing the updated nomenclature was drafted and is presented here.

Main Results:

• A revised and updated nomenclature for human leukocyte antigens has been established.
• The new nomenclature aims to accommodate a growing number of identified antigens and alleles.
• This revision ensures continued standardization in human leukocyte antigen research and clinical applications.

Conclusions:

• The revised human leukocyte antigen nomenclature provides a more comprehensive and accurate system.
• This updated standard is essential for ongoing research in transplantation, autoimmune diseases, and personalized medicine.
• The committee's work ensures the nomenclature remains a vital tool for the global scientific community.